Skip to main content
TipRanks
Go Ultimate75% OFF

InDex Pharmaceuticals Holding AB (FLERIE) Ratios

2 Followers

InDex Pharmaceuticals Holding AB Ratios

SE:FLERIE's free cash flow for Q3 2026 was kr500.00K. For the 2026 fiscal year, SE:FLERIE's free cash flow was increased by kr0.00 and operating cash flow was kr500.00K. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio52.3155.395.0423.5741.93
Quick Ratio52.3155.395.0423.5741.93
Cash Ratio38.8646.765.0023.4140.55
Solvency Ratio-37.26-8.99-1.55-5.71-9.12
Operating Cash Flow Ratio-2.02-0.92-0.64-8.78-11.74
Short-Term Operating Cash Flow Coverage0.00-42.500.000.0020676.33
Net Current Asset Valuekr 706.80Mkr 999.40Mkr 236.11Mkr 329.97Mkr 431.88M
Leverage Ratios
Debt-to-Assets Ratio0.000.000.010.010.00
Debt-to-Equity Ratio0.000.000.010.010.00
Debt-to-Capital Ratio0.000.000.010.010.00
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.011.011.251.051.03
Debt Service Coverage Ratio-54.20-53.81-413.31-826.23-800.46
Interest Coverage Ratio-57.09-29.16-472.98-1259.28-869.40
Debt to Market Cap0.000.000.000.00-0.00
Interest Debt Per Share0.200.070.050.060.03
Net Debt to EBITDA0.723.833.113.454.20
Profitability Margins
Gross Profit Margin-144.32%-41600.00%95.74%0.00%0.00%
EBIT Margin-8456.82%-226500.00%-97.47%0.00%0.00%
EBITDA Margin-8450.00%-225900.00%-96.22%0.00%0.00%
Operating Profit Margin-8887.50%-110800.00%-110.11%0.00%0.00%
Pretax Profit Margin-8612.50%-227900.00%-97.70%0.00%0.00%
Net Profit Margin-8601.14%-228000.00%-97.70%0.00%0.00%
Continuous Operations Profit Margin-8601.14%-228000.00%-97.70%0.00%0.00%
Net Income Per EBT99.87%100.04%100.00%100.00%100.00%
EBT Per EBIT96.91%205.69%88.73%66.40%89.11%
Return on Assets (ROA)-22.28%-5.40%-31.82%-28.56%-23.15%
Return on Equity (ROE)-22.41%-5.43%-39.88%-30.04%-23.74%
Return on Capital Employed (ROCE)-23.12%-2.64%-44.65%-44.89%-26.60%
Return on Invested Capital (ROIC)-23.08%-2.63%-44.52%-44.81%-26.56%
Return on Tangible Assets-22.28%-5.40%-31.82%-28.56%-23.15%
Earnings Yield-29.63%-7.88%-3.32%-3.50%-3.96%
Efficiency Ratios
Receivables Turnover0.040.0042.520.000.00
Payables Turnover15.3669.500.620.160.28
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover5.180.1035.160.000.00
Asset Turnover0.000.000.330.000.00
Working Capital Turnover Ratio0.010.000.340.000.00
Cash Conversion Cycle9441.35539099.75-583.42-2246.50-1311.03
Days of Sales Outstanding9465.11539105.008.580.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding23.775.25592.012246.501311.03
Operating Cycle9465.11539105.008.580.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-0.36-0.24-0.71-2.43-2.57
Free Cash Flow Per Share-0.36-0.24-0.71-2.43-2.57
Dividend Paid and CapEx Coverage Ratio-1.000.000.000.000.00
Capital Expenditure Coverage Ratio-1.000.000.000.000.00
Operating Cash Flow Coverage Ratio-13.38-21.25-16.53-39.80-96.77
Operating Cash Flow to Sales Ratio-3.19-170.00-0.390.000.00
Free Cash Flow Yield-1.10%-0.59%-1.33%-4.52%-4.77%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-3.37-12.68-30.08-28.56-25.24
Price-to-Sales (P/S) Ratio290.2828949.5129.390.000.00
Price-to-Book (P/B) Ratio0.760.6912.008.585.99
Price-to-Free Cash Flow (P/FCF) Ratio-90.91-170.29-75.46-22.14-20.96
Price-to-Operating Cash Flow Ratio-90.91-170.29-75.46-22.14-20.96
Price-to-Earnings Growth (PEG) Ratio-0.020.155.902.462.09
Enterprise Value Multiple-2.71-8.99-27.43-25.46-21.38
Enterprise Value2.02B2.03B2.57B2.52B2.17B
EV to EBITDA-2.71-8.99-27.43-25.46-21.38
EV to Sales229.1320306.5126.400.000.00
EV to Free Cash Flow-71.76-119.45-67.78-19.50-17.52
EV to Operating Cash Flow-71.76-119.45-67.78-19.50-17.52
Tangible Book Value Per Share43.3259.574.486.278.98
Shareholders’ Equity Per Share43.3259.574.486.278.98
Tax and Other Ratios
Effective Tax Rate0.00-0.000.000.000.00
Revenue Per Share0.110.001.830.000.00
Net Income Per Share-9.71-3.24-1.79-1.88-2.13
Tax Burden1.001.001.001.001.00
Interest Burden1.021.011.001.001.00
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.0069.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.040.070.401.291.20

Currency in SEK